Chemomab Therapeutics (NASDAQ: CMMB), is a clinical-stage biotech company, focusing on discovery and development of innovative therapeutics for fibrosis-related diseases.

Pharmaceutical

Chemomab

Chemomab's headquarters in Tel Aviv-Yafo, Israel

Adi Mor

David Weiner

Yonatan Cohavi

Revital Aricha

Jack Lawler

Barbara Lindheim

Alan Moses

Scott L. Friedman

Nissim Darvish

Marco Matucci-Cerinic

Claude Nicaise

Neil Cohen

Massimo Pinzani

Dinesh Khanna

Jacob George

Francesco Del Galdo

Arun Sanyal

Jill M. Quigley

The Scientific Team at Chemomab Therapeutics is a group of highly specialized professionals dedicated to advancing the discovery and development of innovative therapeutics for fibrosis-related diseases. This team collaborates to conduct cutting-edge research, design clinical trials, and translate scientific discoveries into effective treatments, ensuring the company's leadership in the biotech industry.

Scientific Team

The Leadership Team at Chemomab is responsible for setting the strategic direction and vision of the company, guiding the development of innovative therapeutics for fibrosis-related diseases. Comprising experienced co-founders and scientific leaders, they oversee research initiatives, ensure alignment with clinical objectives, and drive decision-making to foster growth and success in the biotechnology sector.

Leadership Team

The Clinical Operations Team at Chemomab is responsible for planning, executing, and managing clinical trials to support the development of innovative therapeutics for fibrosis-related diseases. They ensure regulatory compliance, oversee clinical trial logistics, and collaborate with clinical sites and investigators to achieve trial objectives efficiently and effectively.

Clinical Operations Team

Chemomab

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Clinical Operations Team

Offices

Chemomab

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Clinical Operations Team

Offices

Related companies